Exact Mass: 254.0779
Exact Mass Matches: 254.0779
Found 500 metabolites which its exact mass value is equals to given mass value 254.0779,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Ketoprofen
Ketoprofen is only found in individuals that have used or taken this drug. It is a propionic acid derivative and is a nonsteroidal anti-inflammatory agent (NSAIA) with analgesic and antipyretic properties. The anti-inflammatory effects of ketoprofen are believed to be due to inhibition cylooxygenase-2 (COX-2), an enzyme involved in prostaglandin synthesis via the arachidonic acid pathway. This results in decreased levels of prostaglandins that mediate pain, fever and inflammation. Ketoprofen is a non-specific cyclooxygenase inhibitor and inhibition of COX-1 is thought to confer some of its side effects, such as GI upset and ulceration. Ketoprofen is thought to have anti-bradykinin activity, as well as lysosomal membrane-stabilizing action. Antipyretic effects may be due to action on the hypothalamus, resulting in an increased peripheral blood flow, vasodilation, and subsequent heat dissipation. M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics CONFIDENCE standard compound; EAWAG_UCHEM_ID 205 CONFIDENCE standard compound; INTERNAL_ID 1150 CONFIDENCE standard compound; INTERNAL_ID 4086 CONFIDENCE standard compound; INTERNAL_ID 8562 D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors
L-Phosphoarginine
L-Phosphoarginine is found in crustaceans. L-Phosphoarginine is a constituent of crayfish muscle KEIO_ID P105
Chalepensin
D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents > D011564 - Furocoumarins
Anhydroglycinol
Anhydroglycinol, also known as 3,9-dihydroxypterocarpen, is a member of the class of compounds known as pterocarpans. Pterocarpans are benzo-pyrano-furano-benzene compounds, containing the 6H-[1]benzofuro[3,2-c]chromene skeleton. They are derivatives of isoflavonoids. Thus, anhydroglycinol is considered to be a flavonoid lipid molecule. Anhydroglycinol is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Anhydroglycinol can be found in common beet, which makes anhydroglycinol a potential biomarker for the consumption of this food product.
2-Hydroxyfelbamate
2-Hydroxyfelbamate is a metabolite of felbamate. Felbamate (marketed under the brand name Felbatol by MedPointe) is an anti-epileptic drug used in the treatment of epilepsy. It is used to treat partial seizures (with and without generalization) in adults and partial and generalized seizures associated with Lennox-Gastaut syndrome in children. However, an increased risk of potentially fatal aplastic anemia and/or liver failure limit the drugs usage to severe refractory epilepsy. (Wikipedia)
p-Hydroxyfelbamate
p-Hydroxyfelbamate is a metabolite of felbamate. Felbamate (marketed under the brand name Felbatol by MedPointe) is an anti-epileptic drug used in the treatment of epilepsy. It is used to treat partial seizures (with and without generalization) in adults and partial and generalized seizures associated with Lennox-Gastaut syndrome in children. However, an increased risk of potentially fatal aplastic anemia and/or liver failure limit the drugs usage to severe refractory epilepsy. (Wikipedia)
Isopropylthioxanthone
CONFIDENCE standard compound; INTERNAL_ID 4181
Rubiadin
Rubiadin is a dihydroxyanthraquinone that is anthracene-9,10-dione substituted by hydroxy groups at positions 1 and 3 and a methyl group at position 2. It has been isolated from Rubia yunnanensis. It has a role as an antibacterial agent, an antioxidant, a hepatoprotective agent and a plant metabolite. Rubiadin is a natural product found in Coprosma tenuicaulis, Prismatomeris tetrandra, and other organisms with data available. A dihydroxyanthraquinone that is anthracene-9,10-dione substituted by hydroxy groups at positions 1 and 3 and a methyl group at position 2. It has been isolated from Rubia yunnanensis. Rubiadin is a dihydroxy anthraquinone isolated from Rubia cordifolia. Rubiadin has a potent antixidant activity[1]. Rubiadin is a dihydroxy anthraquinone isolated from Rubia cordifolia. Rubiadin has a potent antixidant activity[1].
4\\%27,7-Dihydroxyflavone
4,7-dihydroxyflavone is a dihydroxyflavone in which the two hydroxy substituents are located at positions 4 and 7. It has a role as a metabolite. 7,4-Dihydroxyflavone is a natural product found in Dracaena cinnabari, Thermopsis macrophylla, and other organisms with data available. See also: Glycyrrhiza uralensis Root (part of); Glycyrrhiza inflata root (part of). A dihydroxyflavone in which the two hydroxy substituents are located at positions 4 and 7. 7,4'-Dihydroxyflavone (7,4'-DHF) is a flavonoid isolated from Glycyrrhiza uralensis, the eotaxin/CCL11 inhibitor, has the ability to consistently suppress eotaxin production and prevent dexamethasone (Dex)‐paradoxical adverse effects on eotaxin production[1]. 7,4'-Dihydroxyflavone (7,4'-DHF) inhibits MUC5AC gene expression, mucus production and secretion via regulation of NF-κB, STAT6 and HDAC2. 7,4'-Dihydroxyflavone (7,4'-DHF) decreases phorbol 12-myristate 13-acetate (PMA) stimulated NCI-H292 human airway epithelial cell MUC5AC gene expression and mucus production with IC50 value of 1.4 μM[1]. 7,4'-Dihydroxyflavone (7,4'-DHF) is a flavonoid isolated from Glycyrrhiza uralensis, the eotaxin/CCL11 inhibitor, has the ability to consistently suppress eotaxin production and prevent dexamethasone (Dex)‐paradoxical adverse effects on eotaxin production[1]. 7,4'-Dihydroxyflavone (7,4'-DHF) inhibits MUC5AC gene expression, mucus production and secretion via regulation of NF-κB, STAT6 and HDAC2. 7,4'-Dihydroxyflavone (7,4'-DHF) decreases phorbol 12-myristate 13-acetate (PMA) stimulated NCI-H292 human airway epithelial cell MUC5AC gene expression and mucus production with IC50 value of 1.4 μM[1].
1-(2-hydroxy-4-methoxyphenyl)-3-phenylprop-2-en-1-one
5,7-Dihydroxyisoflavone
5,7-Dihydroxyisoflavone is found in nuts. 5,7-Dihydroxyisoflavone is isolated from hydrolysed flour of Arachis hypogaea (peanut) Mefenamic acid, an anthranilic acid derivative, is a member of the fenamate group of nonsteroidal anti-inflammatory drugs (NSAIDs). It exhibits anti-inflammatory, analgesic, and antipyretic activities. Similar to other NSAIDs, mefenamic acid inhibits prostaglandin synthetase D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors Isolated from hydrolysed flour of Arachis hypogaea (peanut). 5,7-Dihydroxyisoflavone is found in peanut and nuts. D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors
3-(2-hydroxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one
L-Agaridoxin
L-Agaridoxin is found in mushrooms. L-Agaridoxin is a constituent of Agaricus campestris (field mushroom)
3,6-Dimethoxy-4-phenanthrenol
3,6-Dimethoxy-4-phenanthrenol is found in opium poppy. 3,6-Dimethoxy-4-phenanthrenol is found in opiu
2,6-Dimethoxy-4-phenanthrenol
2,6-Dimethoxy-4-phenanthrenol is found in poppy seeds, opium poppy and opium extracts. Found in opium extracts
Dexketoprofen
Dexketoprofen belongs to a class of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). It works by blocking the action of a substance in the body called cyclo-oxygenase. Cyclo-oxygenase is involved in the production of chemicals in the body called prostaglandins. Prostaglandins are produced in response to injury or certain diseases and would otherwise go on to cause swelling, inflammation and pain. By blocking cyclo-oxygenase, dexketoprofen prevents the production of prostaglandins and therefore reduces inflammation and pain. Along with Peripheral analgesic action it possesses central analgesic action. Dexketoprofen is a non-steroidal anti-inflammatory drug. It is manufactured by Menarini, under the tradename Keral. It is available in the UK, as dexketoprofen trometamol, as a prescription-only drug and in Latin America as Miracox, produced by Stein in Costa Rica. In Italy it is available as an over the counter-drug under the tradename Enantyum. In Lithuania it is available as over the counter-drug uder tradename Dolmen. M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
Acetaminophen cystein
Acetaminophen cystein is a metabolite of acetaminophen.
2-Acetylaminophenoxazin-3-one
2-Acetylaminophenoxazin-3-one (AAPO) is a benzoxazinoid metabolite. It was found excreted in the feces of rats that were fed a rye bread-based diet which makes this compound a potential fecal biomarker of whole grain intake (PMID: 23113707).
Butanoic acid, [(diethoxyphosphinyl)oxy]methyl ester
Fenbufen
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors
Indolocarbazole
Nordalbergin
Nordalbergin is a neoflavonoid. Nordalbergin, a coumarin isolated from the wood bark of Dalbergia sissoo. Nordalbergin shows strong activity in the induction of differentiation of HL-60[1]. Nordalbergin, a coumarin isolated from the wood bark of Dalbergia sissoo. Nordalbergin shows strong activity in the induction of differentiation of HL-60[1].
Alizarin 1-methyl ether
2-Hydroxy-1-methoxyanthraquinone could be isolated from the stem bark of Morinda lucida Benth. (Rubiaceae) and possesses antibacterial activity[1].
4-Phenyl 5,7-dihydroxycoumarin
4-Phenyl-7,8-dihydroxycoumarin is a coumarin derivative and can be used for bronchiectasiss research[1].
serratin
5,7-Dihydroxy-4-phenylcoumarin is a natural product found in Passiflora serratodigitata with data available. CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2345 INTERNAL_ID 2345; CONFIDENCE Reference Standard (Level 1) LC3-mHTT-IN-AN2 (Compound AN2) is a mHTT-LC3 linker compound, which interacts with both mutant huntingtin protein (mHTT) and LC3B but not with wtHTT or irrelevant control proteins. LC3-mHTT-IN-AN2 reduces the levels of mHTT in an allele-selective manner in cultured Huntington disease (HD) mouse neurons[1]. LC3-mHTT-IN-AN2 (Compound AN2) is a mHTT-LC3 linker compound, which interacts with both mutant huntingtin protein (mHTT) and LC3B but not with wtHTT or irrelevant control proteins. LC3-mHTT-IN-AN2 reduces the levels of mHTT in an allele-selective manner in cultured Huntington disease (HD) mouse neurons[1].
fenbufen
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors
2-Isopropyltioxanthone
CONFIDENCE standard compound; INTERNAL_ID 1081; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10555; ORIGINAL_PRECURSOR_SCAN_NO 10552 CONFIDENCE standard compound; INTERNAL_ID 1081; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10557; ORIGINAL_PRECURSOR_SCAN_NO 10552 CONFIDENCE standard compound; INTERNAL_ID 1081; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10555; ORIGINAL_PRECURSOR_SCAN_NO 10550 CONFIDENCE standard compound; INTERNAL_ID 1081; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10599; ORIGINAL_PRECURSOR_SCAN_NO 10598 CONFIDENCE standard compound; INTERNAL_ID 1081; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10624; ORIGINAL_PRECURSOR_SCAN_NO 10623 CONFIDENCE standard compound; INTERNAL_ID 1081; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10619; ORIGINAL_PRECURSOR_SCAN_NO 10616 CONFIDENCE standard compound; INTERNAL_ID 2465 CONFIDENCE standard compound; INTERNAL_ID 8800 CONFIDENCE standard compound; INTERNAL_ID 8204
2-{[1-Cyano-2-(dimethylamino)vinyl]sulfonyl}-3-(dimethylamino)acrylonitrile
5-Methoxyflavanone
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.122 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.121
4-methoxy-3-methylnaphto[1,2-b]oxepin-2(3H)-one|aggregatin B
(3R,4R)-3,4-dihydro-4,8-dihydroxy-6,7-dimethoxy-3-methylisocoumarin|3,4-Dihydro-4,8-dihydroxy-6,7-dimethoxy-3-methyl-1H-2-benzopyran-1-one
4-Acetoxy-3,5-dimethoxy-benzoesaeure-methylester|4-acetoxy-3,5-dimethoxy-benzoic acid methyl ester|Acetylsyringasaeure-methylester|AMS|methyl 4-acetoxy-3,5-dimethoxybenzoate|methyl 4-acetyl syringate
Me ether-2,3-Dihydro-3-hydroxy-2-phenyl-4H-1-benzopyran-4-one
9-methyl-6a,11a-dihydro-6H-benzofuro[3,2-c]chromen-3-ol
4-[4-hydroxy-3-methoxyphenyl]-indan-1-one|afzeliindanone
9H-Pyrido(3,4-b)indole-3-carboxylic acid, 1-acetyl-
3-O-Methylcyclopolsaeure|3-O-Metyl-cyclopolsaeure|Me ether-Cyclopolic acid
methyl (2Z,4E)-6(acetyloxy)-5-formyl-7-oxoocta-2,4-dienoate
4-(2,3-dihydroxy-5-methoxy-4-methylphenyl)-4-oxobutanoic acid
2,7-dihydroxy-1-methyl-5-aldehyde-9,10-dihydrophenanthrene|2,7-dihydroxy-1-methyl-9,10-dihydrophenanthrene-5-carbaldehyde
3-Ethoxycarbonyl-2-hydroxy-6-methoxy-4-methylbenzoic acid
3-Hydroxy-5-methoxy-benzalacetophenon|3-hydroxy-5-methoxybenzalacetophenone
(3R*,4S*)-3,4-dihydro-3,4,8-trihydroxy-3-(hydroxymethyl)-6-methoxynaphthalen-1(2H)-one|balticol C
1,12-diacetoxy-7-phenylhept-2c-ene-4,6-diyne|3-Me ether,1-Ac-(Z)-7-(3-Hydroxyphenyl)-2-phenyl-4,6-diyn-1-ol
2-Formyl-azobenzol-carbonsaeure-(2)|2-(2-Formyl-phenylazo)-benzoesaeure|2-(2-formyl-phenylazo)-benzoic acid|Benzaldehyd-(2 azo 2)-benzoesaeure
5-hydroxymethyl-2-(4-hydroxyphenyl)-3-methylbenzofuran
(5S,7S)-7-acetoxy-5,10-dihyroxy-Delta8,9dolichodial|jatamanin M
ketoprofen
M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors relative retention time with respect to 9-anthracene Carboxylic Acid is 1.070 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.068 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.071
6-(2-methylbut-3-en-2-yl)furo[3,2-g]chromen-7-one
6-methoxy-2-phenyl-2,3-dihydrochromen-4-one
2-(4-methoxyphenyl)-2,3-dihydrochromen-4-one
(4S,5Z,6S)-4-(2-methoxy-2-oxoethyl)-5-[2-[(E)-3-phenylprop-2-enoyl]oxyethylidene]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylic acid
Dexketoprofen
M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
3-Ethyl-5-[2-(3-methyloxazolidin-2-ylidene)ethylidene]-2-thioxooxazolidin-4-one
2-(3-(METHYLAMINO)PROPYL)ISOINDOLINE-1,3-DIONE HYDROCHLORIDE
3-methyl-N-(4-methylphenyl)-1,3-benzothiazol-2-imine
2-(6-oxocyclohexa-2,4-dien-1-ylidene)-1,3-dihydrobenzimidazole-4-carboxylic acid
2-Propen-1-one,1-(2-hydroxyphenyl)-3-(3-methoxyphenyl)-
sulfadicramide
S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AB - Sulfonamides C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent
3-(PIPERIDIN-4-YL)BENZO[D]OXAZOL-2(3H)-ONE HYDROCHLORIDE
Dimethyl 2,5-dioxobicyclo[2.2.2]octane-1,4-dicarboxylate
N-[4-(4-Pyridinyl)-1,3-thiazol-2-yl]-3-pyridinamine
4-chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol
4-[5-(4-oxocyclohexa-2,5-dien-1-ylidene)-1,3,4-oxadiazolidin-2-ylidene]cyclohexa-2,5-dien-1-one
N-(4-CYANO-3-(TRIFLUOROMETHYL)PHENYL)METHACRYLAMIDE
4-Phenyl-2,6-diamino-4H-thiopyran-3,5-dicarbonitrile
2-DEOXY-2,2-DIFLUORO-4,5-O-(1-METHYLETHYLIDENE)-L-ERYTHRO-PENTONIC ACID, ETHYL ESTER
Methyl 2-(pyridin-4-yl)benzo[d]oxazole-7-carboxylate
(6-CHLOROPYRIDAZIN-3-YL)(4-ETHYLPIPERAZIN-1-YL)METHANONE
3-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol
5-(2-FURYL)-1-PHENYL-1H-PYRAZOLE-3-CARBOXYLIC ACID
2-(1,3-benzodioxol-5-yl)imidazo[1,2-a]pyrimidin-3-amine
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carboxylic acid
6,6,6-TRIFLUORO-3,5-DIOXO-HEXANOIC ACID, 1,1-DIMETHYLETHYL ESTER
1-acetyl-5(3)-phenyl-3(5)-(trifluoromethyl)pyrazole
2-(3-HYDROXY-PHENYL)-3H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID
2,4-DIHYDRO-5-(4-FLUOROPHENYL)-2-PHENYL-3H-PYRAZOL-3-ONE
4-phenyl-3-pyridin-3-yl-1H-1,2,4-triazole-5-thione
(7R)-2-Chloro-7-ethyl-7,8-dihydro-8-(1-methylethyl)-6(5H)-pteridinone
potassium,1,2-bis(ethenyl)benzene,2-methylprop-2-enoate
3-Chloro-4-hydroxyphenylboronic acid, pinacol ester
2-(2-DIMETHYLAMINOETHOXY)-3-HYDROXYPYRIDINE DIHYDROCHLORIDE
phenobarbital sodium
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C67084 - Barbiturate D065693 - Cytochrome P-450 Enzyme Inducers > D065695 - Cytochrome P-450 CYP2B6 Inducers D065693 - Cytochrome P-450 Enzyme Inducers > D065701 - Cytochrome P-450 CYP3A Inducers D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
7-Methyl-1-phenyl-1H-pyrido[2,3-d][1,3]oxazine-2,4-dione
ethyl 2-methyl-2-(2-methyl-4-sulfanyl-phenoxy)propanoate
4-phenyl-3-pyridin-4-yl-1H-1,2,4-triazole-5-thione
Methyl 3-methoxy-2-(2-methoxy-2-oxoethoxy)benzoate
4-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol
ETHYL (2E)-3-[4-[AMINO(IMINO)METHYL]PHENYL]ACRYLATE HYDROCHLORIDE
1H-1,2,4-Triazole-3-carboxamide,N-[5-(2-methoxyethyl)-1,3,4-thiadiazol-2-yl]
2-[1-Methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]benzaldehyde
3,4-dihydro-2h-1,5-benzodioxepin-7-yl(phenyl)methanone
2-(4-HYDROXY-PHENYL)-3H-BENZOIMIDAZOLE-4-CARBOXYLIC ACID
2-Chloro-1-(3-Methyl-2,3,5,6-tetrahydro-[1,2]bipyrazinyl-4-yl)-ethanone
Purine-9-beta-D-(2-deoxy-2-fluoro) arabinoriboside
2-Propen-1-one,3-(4-hydroxyphenyl)-1-(4-methoxyphenyl)-
2-CHLORO-3-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PHENOL
2-(2-HYDROXY-PHENYL)-3H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID
2,8-Diazaspiro[4.5]decane, 8-(methylsulfonyl)-, hydrochloride (1:1)
Ethyl (3R,S)-2,2-difluoro-3-hydroxy-3-(2,2-dimethyldioxolan-4-yl)propionate
3-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol
8-(Trifluoromethyl)-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one
3-(4-Chlorophenyl)-3-oxetaneacetic acid ethyl ester
2-HYDROXY-5-IMIDAZO[1,2-A]PYRIMIDIN-2-YL-BENZAMIDE
1-(2-Hydroxy-5-methylphenyl)-3-phenylpropane-1,3-dione
2-(4-HYDROXY-PHENYL)-3H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID
3-[METHOXY(METHYL)CARBAMOYL]-5-NITROPHENYLBORONIC ACID
2-fluoro-2-[4-[(2-methylpropan-2-yl)oxycarbonyl]phenyl]acetic acid
Magnesium levulinate
A - Alimentary tract and metabolism > A12 - Mineral supplements > A12C - Other mineral supplements > A12CC - Magnesium D004791 - Enzyme Inhibitors
N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide
(2S)-5-amino-2-(3,4-dihydroxyanilino)-5-oxopentanoic acid
2,2,2-trifluoro-N-(2-methyl-8-quinolinyl)acetamide
N-(3-hydroxyphenyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
1H-Pyrimido[1,2-a]quinoline-2-carboxylic acid, 1-oxo-, methyl ester
2-(2-Aminopropanoylamino)-2-phenylsulfanylacetic acid
(2R,3R,4S,5R,6S)-2,3,4,5,6,8-hexahydroxy-7-oxooctanoic acid
2-hydroxy-2-[(2R,3S,4R,5S,6R)-3,4,5,6-tetrahydroxy-6-(hydroxymethyl)oxan-2-yl]acetic acid
5,6-Dimethyl-3-[5-(trifluoromethyl)pyridin-2-yl]-1,2,4-triazine
3-(4,7-Dimethoxy-1,3-benzodioxol-5-yl)propanoic acid
3-(6,7-Dimethoxy-1,3-benzodioxol-5-yl)propanoic acid
3-(6,7-Dimethoxy-1,3-benzodioxol-5-yl)-2-hydroxypropanal
[3-(6,7-Dimethoxy-1,3-benzodioxol-5-yl)oxiran-2-yl]methanol
3-(6-Hydroxy-2,3,4-trimethoxyphenyl)prop-2-enoic acid
3-(6,7-Dimethoxy-1,3-benzodioxol-5-yl)-3-hydroxypropanal
2-Amino-5-[[amino-(phosphonoamino)methylidene]amino]pentanoic acid
(R)-4-methoxydalbergione
A member of the class of 1,4-benzoquinones that is p-benzoquinone substituted by a methoxy group at position 2 and a 1-phenylallyl group at position 5. Isolated from the heartwood of Dalbergia louveli, it exhibits antiplasmodial activity.
N(Omega)-phospho-L-arginine
An arginine derivative that is L-arginine substituted by a phosphono group at N(omega)-position.
2,3-dihydroxypropyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
2-(4-hydroxy-5-methoxy-2-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)ethyl acetate
2-methoxy-5-[(1s)-1-phenylprop-2-en-1-yl]cyclohexa-2,5-diene-1,4-dione
9-methoxy-3,8-dimethylnaphtho[2,3-b]furan-4-carbaldehyde
3-hydroxy-4-(4-hydroxy-3,5-dimethoxyphenyl)oxolan-2-one
(3r,4s)-4-hydroxyoxolan-3-yl 2,4-dihydroxy-6-methylbenzoate
(2s)-2-amino-4-[(3,4-dihydroxyphenyl)-c-hydroxycarbonimidoyl]butanoic acid
3-hydroxy-5,7-dimethoxy-2-methyl-2,3-dihydro-1-benzofuran-6-carboxylic acid
4,6,8-trihydroxy-3-methoxy-3,7-dimethyl-4h-2-benzopyran-1-one
14-methyl-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2,4,6,11,13,15-hexaen-5-ol
methyl (2z,4e,6s)-6-(acetyloxy)-5-formyl-7-oxoocta-2,4-dienoate
3-methyl-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹²,¹⁶]heptadeca-1(10),2,4,6,14-pentaen-9-one
1-o-caffeoylglycerol
{"Ingredient_id": "HBIN002861","Ingredient_name": "1-o-caffeoylglycerol","Alias": "NA","Ingredient_formula": "C12H14O6","Ingredient_Smile": "C1=CC(=C(C=C1C=CC(=O)OCC(CO)O)O)O","Ingredient_weight": "254.24 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2907","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "5315606","DrugBank_id": "NA"}
1-o-caffoylglycerol
{"Ingredient_id": "HBIN002863","Ingredient_name": "1-o-caffoylglycerol","Alias": "NA","Ingredient_formula": "C12H14O6","Ingredient_Smile": "C1=CC(=C(C=C1C=CC(=O)OCC(CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "30716","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1-o-coumaroylglycerol; (s,e)-form,3'-hydroxy
{"Ingredient_id": "HBIN002869","Ingredient_name": "1-o-coumaroylglycerol; (s,e)-form,3'-hydroxy","Alias": "NA","Ingredient_formula": "C12H14O6","Ingredient_Smile": "NA","Ingredient_weight": "254.24","OB_score": "NA","CAS_id": "138812-55-2","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9139","PubChem_id": "NA","DrugBank_id": "NA"}
2-hydroxy-3,7-dimethoxyphenanthrene
{"Ingredient_id": "HBIN005740","Ingredient_name": "2-hydroxy-3,7-dimethoxyphenanthrene","Alias": "NA","Ingredient_formula": "C16H14O3","Ingredient_Smile": "COC1=CC2=C(C=C1)C3=CC(=C(C=C3C=C2)O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10033","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-oxobicyclo(3. 2. 2)nona- 3,6- dien- 1- yl benzoate
{"Ingredient_id": "HBIN006279","Ingredient_name": "2-oxobicyclo(3. 2. 2)nona- 3,6- dien- 1- yl benzoate","Alias": "NA","Ingredient_formula": "C16H14O3","Ingredient_Smile": "C1CC2C=CC1C=C(C2=O)OC(=O)C3=CC=CC=C3","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41568","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(7S,8R)-dihydrodehydrodiconiferylalcohol-4-O-(β-D-glucopyranoside
{"Ingredient_id": "HBIN013475","Ingredient_name": "(7S,8R)-dihydrodehydrodiconiferylalcohol-4-O-(\u03b2-D-glucopyranoside","Alias": "NA","Ingredient_formula": "C16H14O3","Ingredient_Smile": "CC1C(OC2=C1C=C(C=C2)C=O)C3=CC=C(C=C3)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41995","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(7S,8R)-dlihydrodehydrodiconiferyl alcohol-9-o-bei-D-glucoside
{"Ingredient_id": "HBIN013476","Ingredient_name": "(7S,8R)-dlihydrodehydrodiconiferyl alcohol-9-o-bei-D-glucoside","Alias": "NA","Ingredient_formula": "C16H14O3","Ingredient_Smile": "CC1C(OC2=C1C=C(C=C2)C=O)C3=CC=C(C=C3)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "42857","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
